Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

TARGET Study: Safety and Performance of the Cardiovalve TR Replacement System

NCT: NCT05486832 · ACTIVE_NOT_RECRUITING

NCT IDNCT05486832
StatusACTIVE_NOT_RECRUITING
Start Date2022-12-09
Completion2031-12-15

Brief Summary

The objective of this study is to evaluate the safety and performance of Cardiovalve TR system

Frequently Asked Questions

What is TARGET Study: Safety and Performance of the Cardiovalve TR Replacement System?

TARGET Study: Safety and Performance of the Cardiovalve TR Replacement System is a clinical trial registered under NCT05486832. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT05486832?

The current status of NCT05486832 (TARGET Study: Safety and Performance of the Cardiovalve TR Replacement System) is: ACTIVE_NOT_RECRUITING.

When did TARGET Study: Safety and Performance of the Cardiovalve TR Replacement System start?

TARGET Study: Safety and Performance of the Cardiovalve TR Replacement System started on 2022-12-09.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑